首页> 外文期刊>The Lancet >HIV/AIDS treatment and HIV vaccines for Africa.
【24h】

HIV/AIDS treatment and HIV vaccines for Africa.

机译:非洲的艾滋病毒/艾滋病治疗和艾滋病毒疫苗。

获取原文
获取原文并翻译 | 示例
           

摘要

Increased support from the global HIV/AIDS community is driving advances in HIV treatment and vaccine development in the developing world. Care of patients with AIDS includes many biomedical, nutritional, psychosocial, and behavioural interventions. In resource-poor settings, antiretroviral drugs should be given with use of standardised treatment regimens and streamlined algorithms for monitoring use. A safe and effective HIV vaccine will supplement prevention efforts to protect uninfected people against infection, or might possibly be able to modify the course of HIV infection. Advances have been made in understanding the immune response and immunisation to HIV, and new ideas for candidate vaccines have been developed, including several based on HIV-1 strains prevalent in Africa. HIV vaccine efficacy trials are needed in Africa to determine whether these advances can be translated into clinical and public health benefits. In this review, we discuss the prospects for use of treatment and vaccines in resource-poor settings.
机译:全球艾滋病毒/艾滋病社区越来越多的支持正在推动发展中国家在艾滋病毒治疗和疫苗开发方面取得进展。艾滋病患者的护理包括许多生物医学,营养,社会心理和行为干预。在资源匮乏的地区,应使用标准化的治疗方案和简化的算法来监测抗逆转录病毒药物的使用情况。安全有效的HIV疫苗将补充预防工作,以保护未感染者免受感染,或者可能能够改变HIV感染的过程。在了解对HIV的免疫应答和免疫方面已取得了进展,并且候选疫苗的新构想也得到了发展,包括几种基于非洲流行的HIV-1菌株的疫苗。非洲需要进行HIV疫苗功效试验,以确定这些进展是否可以转化为临床和公共卫生利益。在这篇综述中,我们讨论了在资源匮乏地区使用治疗和疫苗的前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号